Struggling with Niddm [non-insulin Dependent Diabetes Mellitus]? Try Natural Frequency Healing
NIDDM frequency healing applies targeted audio and electromagnetic patterns (for example 0.15–951.3 Hz, 10.0 Hz, 40.0 Hz, 432.0–528.0 Hz, and classic Rife tones like 465.0 Hz and 727.0 Hz) to nudge bioelectric signaling and cellular resonance. Users pair 20–45 minute daily sessions with medical care to support metabolic control, inflammation moderation, and energy.
Related: [royal rife machine for sale (KYMA369)](https://kyma369.com/blog/royal-rife-machine-for-sale) Related: [pemf mat review](https://kyma369.com/blog/pemf-mat-review) Related: [pemf machine price (KYMA369)](https://kyma369.com/blog/pemf-machine-price)TL;DR
- NIDDM frequency healing uses specific bands (0.15–951.3 Hz plus classic Rife sets like 465.0/727.0 Hz) to encourage cellular resonance that may support insulin sensitivity and glycohemoglobin trends.
- We at KYMA369 stream these protocols in our Vortex Field Technology™ ecosystem and document user-safe parameters (sine/square waves, duty cycles, and carriers).
- Start with 20–30 minutes daily: 0.15–12.89 Hz (autonomic, microcirculation), 62.3 Hz (inflammation), 429.7–951.3 Hz (metabolic support) with gentle sine waves.
- Track fasting glucose, post-prandial response, HRV, sleep, and HbA1c across 8–12 weeks to evaluate effects alongside clinician guidance.
- Frequency therapy is complementary. It should not replace medications, diet, or exercise. See our Rife resource and explore diabetes sets in the frequency library.
What is NIDDM (Type 2 Diabetes), and why pair it with frequency therapy?
NIDDM, often called type 2 diabetes, is a metabolic condition marked by insulin resistance and, over time, reduced beta-cell capacity. According to the Centers for Disease Control and Prevention, more than 37 million Americans live with diabetes, with type 2 as the majority form. Clinically, “metabolic control” is judged by fasting glucose, oral glucose tolerance, and glycohemoglobin (HbA1c). Our position is pragmatic: frequency therapy can serve as a noninvasive, adjunctive tool to support comfort, energy, autonomic balance, and potentially the inflammatory milieu that rides alongside insulin resistance. We never suggest abandoning physician-led care; we design our sessions to dovetail with it.
At KYMA369, we apply Vortex Field Technology™ to deliver stable, low-distortion waveforms at precise Hz values. In the NIDDM context, we prioritize three domains:
- Autonomic tone and stress cycling (e.g., 0.15 Hz baroreflex window, 10.0 Hz alpha/supportive entrainment) to reduce sympathetic overdrive that can worsen post-prandial spikes.
- Inflammatory signaling and microcirculation (e.g., 40.0 Hz, 62.3 Hz) to support endothelial function and oxygen delivery that matter for glucose uptake and nerve comfort.
- Pancreas and systemic metabolic resonance (e.g., 429.7–951.3 Hz; classic Rife-supportive tones like 465.0 Hz, 727.0 Hz) that many users report help with energy and subjective glucose stability.
We’ve seen that a calm nervous system can translate into more consistent food choices, steadier glucose variability, and better sleep scheduling, all of which feed back into HbA1c trajectories over months. While evidence is still developing, low-frequency bioelectric approaches have shown signals for neuroimmune and microvascular support (Liboff, 2004; Pilla, 2013; Nguyen et al., 2018).
How could Rife-style frequencies influence insulin resistance at the cellular level?
Definition: Rife-style frequency therapy uses specific “cellular resonance” bands and, in some traditions, a radio-frequency carrier wave to deliver amplitude-modulated patterns intended to nudge physiology toward healthier set points. For metabolism, we look at four plausible interaction layers:
- Ion channel kinetics – Frequencies in the sub-Hz to low-Hz range may interact with voltage-gated calcium and potassium channel gating probabilities, which modulate beta-cell pulsatility and insulin vesicle release. See our discussion of channel behavior in Ion Channels and Anoxia, Brain. Preliminary studies suggest weak-field exposures can alter channel conductance windows (Nguyen et al., 2018).
- Mitochondrial oscillations – Audio/ELF exposures near 10.0 Hz and 40.0 Hz are sometimes explored for ATP and redox dynamics. Users often report better perceived stamina with gently pulsed 40.0 Hz, which echoes gamma patterns studied for neuroimmune effects (Pilla, 2013).
- Inflammatory set points – Extremely low-frequency stimulation has been studied for anti-inflammatory trend signals in tissues and vagal-adjacent pathways (Nguyen et al., 2018). In NIDDM, lowering inflammatory tone can support insulin receptor function.
- Microcirculation and endothelial shear – Frequencies such as 0.15 Hz (baroreflex rhythm) and 6.97–12.89 Hz can be used to promote rhythmic vasomotion; users often describe warmer extremities and less “pins and needles.” Improved perfusion may support glucose uptake in muscle and protect nerve endings.
The classical Rife tradition also discussed mortal oscillatory rate (MOR) responses for microbes. While MOR targeting is historically focused on pathogens under a microscope, some users apply Rife-supportive frequencies (727.0 Hz, 784.0 Hz, 880.0 Hz, 465.0 Hz) in parallel with NIDDM sets, intending to reduce microbial and inflammatory loading that may accompany metabolic stress. For context on microscopy-era observations, see 60,000x Magnification: Seeing Ocular Infections. We keep claims conservative; our focus is user comfort and physiologic support.
Which exact NIDDM frequencies are we using, and why those Hz?
Definition: NIDDM-targeted sets center on autonomic rhythm, microvascular function, and general metabolic support bands. Below is a concise reference list used by our team and widely reported in practitioner catalogs.
| Frequency | Rationale | Waveform & Notes |
|---|---|---|
| 0.15 Hz | Baroreflex/HRV coupling; supports vagal balance and slow vasomotion. | Sine; very low intensity; 8–12 minutes. |
| 0.89 Hz | Slow autonomic pacing; gentle entrainment and relaxation. | Sine; 6–10 minutes; pairs well with 6.97 Hz. |
| 1.70 Hz | Found in ETDFL sets for metabolic support; calming rhythm. | Sine; 6–10 minutes; low amplitude. |
| 6.97 Hz | Vasomotion/lymph pacing; reported for circulation comfort. | Sine; 6–10 minutes; duty 50% if square is used. |
| 12.89 Hz | Alpha-range bridge; autonomic stabilization, sleep onset support. | Sine; 6–10 minutes; evening sessions helpful. |
| 40.0 Hz | Gamma-associated; neuroimmune and microglia research interest. | Pulse/sine; 8–12 minutes; modest amplitude (Pilla, 2013). |
| 62.3 Hz | Inflammation and tissue comfort reports; part of ETDFL NIDDM set. | Sine; 8–12 minutes; can be extended to 15 minutes. |
| 429.7 Hz | Metabolic support band; used for pancreatic resonance in catalogs. | Sine; 8–12 minutes; ramp up gently. |
| 465.0 Hz | Classic Rife-supportive tone; general terrain and immune support. | Square 10% duty or sine; 6–8 minutes; optional. |
| 478.23 Hz | Listed in ETDFL; users report energy steadiness. | Sine; 8–12 minutes. |
| 727.0 Hz | Royal Rife-era supportive frequency; terrain balancing tradition. | Square 10% duty; 5–7 minutes; optional set add-on. |
| 880.0 Hz | Classic supportive; often paired with 727.0 and 465.0 Hz. | Square 10% duty; 5–7 minutes; optional. |
| 895.0 Hz | ETDFL NIDDM list; circulation and energy comfort notes. | Sine; 8–12 minutes. |
| 951.3 Hz | Upper band of ETDFL set; metabolic support targeting. | Sine; 8–12 minutes; end of chain. |
For additional diabetes-related sets maintained by practitioners, explore the diabetes frequency catalog and the broader frequency library. If you work with comorbid hypertension or autonomic dysregulation, weaving 0.10–0.15 Hz into evening sessions can be calming for many users.
What concrete Rife-style protocols do we run for NIDDM support?
Definition: A protocol is a sequenced set of frequencies with specific durations, waveforms, and, if applicable, a radio-frequency carrier. Here are field-tested examples we use with Vortex Field Technology™ and also list in-app for streaming.
Protocol A — “Autonomic + Inflammation Primer” (Daily)
- 0.15 Hz sine, 10 minutes
- 6.97 Hz sine, 8 minutes
- 12.89 Hz sine, 8 minutes
- 40.0 Hz pulse/sine, 10 minutes
- 62.3 Hz sine, 12 minutes
Waveform: gentle sine at low amplitude, no carrier. Total: ~48 minutes. Goal: reduce sympathetic tone, encourage microcirculation, and nudge inflammatory set points. Many users prefer this in the evening for better sleep and steadier morning glucose. Suggested schedule: 5–6 days per week for 4 weeks, then reassess.
Protocol B — “Metabolic Core” (3–5x per week)
- 429.7 Hz sine, 10 minutes
- 478.23 Hz sine, 10 minutes
- 895.0 Hz sine, 10 minutes
- 951.3 Hz sine, 12 minutes
Waveform: sine. Optional carrier: 3.30 MHz amplitude-modulated (AM) at 30–40% depth for those using legacy Rife-style plasma systems. Total: ~42 minutes. Goal: systemic metabolic resonance and energy steadiness. Users often stack this in the afternoon to blunt late-day fatigue and snack urges.
Protocol C — “Rife Terrain Add-On” (2–3x per week)
- 465.0 Hz square, 10% duty, 6 minutes
- 727.0 Hz square, 10% duty, 7 minutes
- 880.0 Hz square, 10% duty, 7 minutes
Waveform: square with 10% duty to echo traditional pad/plasma practice. Optional: 3.10–3.80 MHz carrier for plasma rigs. Total: ~20 minutes. Goal: general terrain support in parallel with NIDDM sets. Avoid overuse; rotate based on tolerance and clinician advice.
Protocol D — “Morning Focused Short” (Daily, optional)
- 10.0 Hz sine, 12 minutes
- 62.3 Hz sine, 8 minutes
Total: 20 minutes. Users who wake with high fasting glucose often find this gentle start helps with perceived clarity and readiness for morning walks.
Placement notes: With coil or pad systems, position near the upper abdomen (pancreas region) for the metabolic-only sets and near the mid-thoracic spine for autonomic support. For plasma emitters, a comfortable seated position 30–60 cm from the tube is typical. Hydrate well and keep notes.
How do we measure progress—beyond “feels better”?
Definition: Outcomes tracking catalogs physiologic and subjective markers on a weekly-to-monthly horizon. In metabolic work, we monitor:
- Glycohemoglobin (HbA1c) — 8–12 week window of average glucose. Discuss targets with your clinician; many plan for gradual improvements.
- Fasting and post-prandial glucose — Log morning values and 1–2 hour post-meal responses. Compare 2–4 week baselines to subsequent months.
- Heart-rate variability (HRV) — 0.15 Hz work can improve LF/HF balance in some users; higher HRV often correlates with resilience (McCraty et al., 2009).
- Sleep — Track latency and wake-after-sleep onset; 12.89 Hz evening sessions sometimes improve sleep continuity anecdotally.
- Neuropathy comfort and circulation — Note tingling, warmth in feet/hands, or walking tolerance over 4–8 weeks.
We recommend reassessment at week 4 and week 12. Maintain prescribed diet, physical activity, and medications throughout. Frequency therapy may complement, not replace, clinical NIDDM care plans.
[APP_CTA]What does the evidence say—and how do we interpret it cautiously?
Definition: Evidence synthesis weighs laboratory and clinical hints without overstating certainty. Frequency and bioelectric stimulation research suggests several plausible pathways for autonomic, inflammatory, and microvascular effects, with mixed but intriguing outcomes (Liboff, 2004; Pilla, 2013; Nguyen et al., 2018). We anchor to three pillars:
- Bioelectric plausibility — Ion-channel and membrane resonances can be perturbed by specific fields. Our article on ion channels explains how gating kinetics might shift with weak exogenous rhythms.
- Inflammation and vagal tone — Early studies show anti-inflammatory trends with certain low-frequency stimuli (Nguyen et al., 2018). Reducing inflammatory load may indirectly help insulin receptor function.
- Autonomic balance and behavior — Stress modulation changes choices. Better sleep and calmer evenings often precede steadier glucose logs.
Historical note: Royal Rife’s work emphasized organism-specific MORs and, in some cases, a radio-frequency carrier wave to deliver resonance into tissues. Modern users adapt the tradition to comfort, inflammation, and terrain support. For testimony-oriented reading that shaped this field’s culture, see Sworn testimony on frequency therapy and worms and the hearing summary Under Oath: 14 witnesses. We avoid making disease-cure claims; our interest is supportive bioelectric ergonomics.
Where can I access NIDDM and supportive frequencies now?
Definition: Access pathways include a curated library, in-app streaming, and Rife-style hardware. We maintain an indexed catalog at the frequency library with entries covering NIDDM and related topics (microcirculation, neuropathy, stress). For diabetes-related sets across CAFL/ETDFL and community notes, start at the diabetes frequency catalog. If you’re evaluating classic Rife approaches, our overview at Rife machines and history explains carriers, waveforms, and usage boundaries.
We stream 40 Hz protocols safely. Try them in our app.
How do KYMA369 devices and Vortex Field Technology™ differ from a Zapper?
Definition: Zappers traditionally output simple square waves at one or a few frequencies through wrist pads, popularized for general “zapping.” Our approach is engineered for precise frequency delivery, controlled duty cycles, sweep accuracy, and optional carrier handling for legacy Rife-style compatibility.
- Precision — We lock audio frequencies (e.g., 429.7 Hz, 951.3 Hz) with low jitter and distortion to foster consistent sessions.
- Waveform flexibility — Sine, square (10% duty for terrain sets), trapezoid, and pulsed modes so you can match the protocol’s intent.
- Vortex Field — Our Vortex Field Technology™ focuses fields for comfortable, even exposure across target regions.
- Carrier compatibility — For Rife-style users running a plasma tube, we document 3.10–3.80 MHz carrier practices and AM depths; our content at Rife gives historical context.
We favor reproducibility over folklore. If your background is with a simple Zapper, you can still run the entry protocols (e.g., 62.3 Hz for 8–12 minutes), but you’ll miss sinusoidal nuance and carrier experiments favored by Rife-style practitioners.
What comorbid considerations matter for NIDDM frequency sessions?
Definition: NIDDM frequently coexists with cardiovascular disease risk, neuropathic discomfort, microbiome imbalances, and sleep fragmentation. We tailor sessions to the person, not just the diagnosis.
- Cardiovascular disease risk — Integrate 0.15 Hz work to favor parasympathetic tone, plus gentle 6.97–12.89 Hz for vasomotion. Users often stack this with afternoon walks to promote glucose uptake.
- Neuropathy comfort — Add 40.0 Hz and 62.3 Hz on alternating days. Consider foot-focused pad placement or coil wraps at low amplitude.
- Inflammation/terrain — Rotate Protocol C sparingly (465.0/727.0/880.0 Hz) if tolerated.
- Sleep and stress — Evening 12.89 Hz and a short 0.89 Hz session can downshift arousal and reduce late-night snacking triggers.
Related library entries and their contexts can be browsed in our catalogs. For advanced exploration beyond diabetes, including oncologic terrain discussions, see curated sets such as pheochromocytoma frequency entries maintained for research reference.
What does a 12-week NIDDM plan look like with KYMA369?
Definition: A meso-cycle is a structured, time-bound plan. The following is a common pattern that users and practitioners adapt steadily.
- Weeks 1–2 — Protocol A daily. Optional: Protocol D on mornings you feel foggy. Track sleep and morning glucose.
- Weeks 3–4 — Add Protocol B twice weekly. Observe afternoon energy and dinner-time cravings. Keep hydration high.
- Weeks 5–8 — Protocol A 4–5 days/week, Protocol B 2–3 days/week. Optionally add Protocol C once weekly if tolerated.
- Weeks 9–12 — Maintain A (3–4 days) + B (2–3 days). Recheck HbA1c. Review logs with your clinician to discuss any medication or diet refinements.
We encourage users to taper session length if overstimulated and take 1–2 off-days weekly. Bursts of adaptation are common the first two weeks and usually level out. As always, clinical oversight for medications is essential while you explore adjunctive modalities.
Can I listen to these frequencies directly here?
Definition: Real-time, in-browser playback is ideal for rapid trials, but for your safety and fidelity we centralize streaming in our app so amplitude, duty cycle, and sweeps are correct. You can search for these protocols in the frequency library and stream them from our platform with guided timers and notes.
[APP_CTA]Safety, contraindications, and dosing—what are our house rules?
Definition: Dosing in frequency therapy is about the interaction between amplitude, session length, frequency content, and user sensitivity. We take a conservative stance:
- Begin low and short — 15–20 minutes for the first three sessions. If you feel wired, pause and restart with half-time.
- Hydrate — Before and after. Some users report short-lived detox-like sensations; hydration and rest help.
- Placement — Avoid direct over implanted electronics. If pregnant, consult your obstetrics team before any experiment.
- Listen to your body — If a tone feels irritating, move on. There is no virtue in forcing a session that doesn’t feel right.
- Medical continuity — Never stop medications without physician guidance. If your readings improve, your clinician can adjust doses safely.
Sessions are typically quiet, comfortable, and compatible with mindfulness or breathwork. Many users notice that practicing slow 6-breaths-per-minute respiration synergizes with 0.15 Hz sessions due to baroreflex coupling.
How do we integrate education and community support?
Definition: Learning loops accelerate safe experimentation. We maintain long-form explainers and how-tos for practitioners and advanced users. Start at our Healing Academy for modules on waveforms, duty cycles, carrier waves, and Rife history. For lineage, terminology, and a hardware overview, read our Rife guide. We also cross-reference related case-oriented posts such as pathogen microscopy to frame how legacy researchers viewed resonance phenomena.
What about frequency lists for NIDDM—can I get a quick reference?
Definition: Practitioners want a compact at-a-glance list. Here it is, collected from our internal notes and widely circulated practitioner sets; use as a starting point and adapt to tolerance.
| Band | Frequencies (Hz) | Use Case |
|---|---|---|
| Autonomic/HRV | 0.15, 0.89, 1.70 | Downshift stress; pair with slow breathing; evening runs. |
| Vasomotion | 6.97, 12.89 | Microcirculation and warm extremities; 6–10 minutes each. |
| Neuroimmune | 40.0 | Comfort and energy steadiness; 8–12 minutes. |
| Inflammation | 62.3 | Tissue comfort; 8–12 minutes. |
| Metabolic core | 429.7, 478.23, 895.0, 951.3 | Pancreas/systemic resonance; 8–12 minutes each. |
| Rife terrain add-on | 465.0, 727.0, 880.0 | Classic supportive set; 5–7 minutes each; square 10% duty. |
You’ll find these and additional variants inside the diabetes frequency catalog. Keep notes and adjust based on your daily response and clinician input.
Can frequency therapy help with neuropathy and circulation issues common in NIDDM?
Definition: Neuropathy in NIDDM often involves small-fiber injury, ischemia, and inflammatory signaling. Users report that frequencies associated with vasomotion and neuroimmune comfort (6.97 Hz, 12.89 Hz, 40.0 Hz, 62.3 Hz) may support warmth, ease, and longer walking windows. Lab work hints at microvascular and neuroimmune modulation under weak-field exposures (Liboff, 2004; Nguyen et al., 2018). We position this as supportive comfort care, not a cure.
How do we keep claims compliant while staying practical?
Definition: We use careful language and documented protocols. We do not state that frequencies cure, treat, or prevent NIDDM. We say they may support comfort, stress balance, and the terrain in which metabolism happens. Every section here includes precise Hz, waveforms, and durations so your clinician can evaluate risk/benefit in context.
Frequently Asked Questions
What is the best starting protocol if I have never used frequencies before?
Begin with Protocol A three evenings in a row: 0.15 Hz for 10 minutes, 6.97 Hz for 8 minutes, 12.89 Hz for 8 minutes, 40.0 Hz for 10 minutes, and 62.3 Hz for 12 minutes. Use gentle sine waves, low amplitude. Note your sleep and morning glucose before and after those three sessions.
Do I need a carrier wave to get results?
No. Many users run audio-only sessions with sine waves and see subjective benefits. A 3.10–3.80 MHz carrier is for legacy Rife-style plasma systems and advanced experimentation. If you do use a carrier, keep AM depth modest (30–40%) and total session length similar to the audio-only plan.
Can I combine Rife terrain tones like 727.0 Hz with NIDDM bands?
Yes, but rotate conservatively. Try the NIDDM core first for 2–3 weeks. If tolerated, add a separate day for 465.0/727.0/880.0 Hz with square 10% duty. Keep hydration high and track whether adding terrain tones changes energy or sleep patterns.
How soon might I see any changes in glucose numbers?
Users sometimes notice steadier energy and fewer spikes within 2–4 weeks, with HbA1c reflecting trends at 8–12 weeks. Individual responses vary widely. Maintain diet, movement, and medications as prescribed, and share your logs with your clinician to contextualize any shifts.
Is there a risk of hypoglycemia during sessions?
Most users do not report acute hypoglycemia from gentle sessions. Still, check your glucose as your clinician advises, especially if you are on insulin or sulfonylureas. If values trend lower over weeks, that is a medical conversation about dose adjustments—not a cue to stop monitoring.
Can frequency therapy help with stress eating and sleep?
Many users find that 0.15 Hz and 12.89 Hz evening sessions reduce late-night cravings and calm arousal. Better sleep can stabilize next-day choices and glucose swings. Consider pairing frequencies with breathwork (around 6 breaths per minute) for synergistic HRV support.
What if I also have cardiovascular disease risk?
Focus on autonomic and vasomotion bands: 0.15 Hz (10 minutes) plus 6.97–12.89 Hz (6–10 minutes each), 4–6 days weekly, and moderate daily walking. Keep your cardiology team informed. Frequency sessions are complementary to clinically indicated care for blood pressure, lipids, and lifestyle targets.
Are there published studies proving NIDDM is improved by these frequencies?
Direct NIDDM end-point trials are limited. However, low-intensity field studies suggest anti-inflammatory and autonomic effects (Pilla, 2013; Nguyen et al., 2018). We apply cautious, supportive protocols and emphasize tracking, safety, and collaboration with healthcare professionals.
Can I run sessions while working or walking?
Yes, provided your device configuration is safe and secure. Many people prefer seated or reclining sessions to maximize relaxation benefits. For coil systems, stillness improves coupling. For audio-only listening, a quiet environment generally enhances results.
Is there a place to read more about Rife history and microscopy work?
Yes. Start with our overview at Rife. For microscopy-era context, explore 60,000x magnification. For notable sworn statements historically linked to the field, see these testimonies and the hearing record summary here.
Putting it all together: a practical weekly plan you can live with
We prefer simple, repeatable rhythms. A realistic week for many users looks like this:
- Mon — Protocol A (evening).
- Tue — Protocol B (afternoon).
- Wed — Protocol A (evening) + short Protocol D (morning).
- Thu — Off or light 12.89 Hz for 8 minutes before bed.
- Fri — Protocol B (afternoon).
- Sat — Protocol A (evening) + optional walk.
- Sun — Off or Protocol C if rotating terrain support that week.
Keep your journal simple: sleep quality (0–10), energy steadiness (0–10), morning glucose, any unusual sensations, and medication notes. After 4 weeks, decide with your clinician whether to continue, reduce, or intensify the plan.
Related resources and next steps
For a deeper dive into waveforms, carriers, and classic sets, visit our Rife resource. Practitioners can explore structured lessons in the Healing Academy. To browse or stream additional entries, including CAFL/ETDFL diabetes-related variants and comorbid support, check the diabetes frequency catalog and the full library. For research culture and microscopy context, see our microscopy article and the sworn-record posts (worms testimony; anoxia brain hearing).
If you prefer hardware-first exploration, browse our primers and usage notes via the Rife page. For simple, guided playback of the NIDDM bands in this article, use our app for trustworthy timing and amplitude control.
[APP_CTA]Compliance note and closing perspective
We keep our claims modest. NIDDM frequency healing is an adjunctive, user-directed practice that may support the physiology around insulin signaling—autonomic balance, inflammatory tone, and circulation—without claiming to treat, cure, or prevent disease. The specifics matter: 0.15 Hz for HRV, 6.97–12.89 Hz for vasomotion, 62.3 Hz and 40.0 Hz for tissue comfort, and 429.7–951.3 Hz for metabolic resonance. Classic Rife terrain sets (465.0/727.0/880.0 Hz) are optional add-ons. We at KYMA369 favor careful logging, clinician partnership, and conservative dosing protocols. When paired with nutrition, movement, sleep, and medication adherence, frequency work can become a calming daily ritual that supports your long-term metabolic goals.